{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:50Z","timestamp":1761919670804},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11011-013-9391-5","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T02:27:05Z","timestamp":1362191225000},"page":"327-331","source":"Crossref","is-referenced-by-count":12,"title":["Ornithine phenylacetate revisited"],"prefix":"10.1007","volume":"28","author":[{"given":"Maria","family":"Jover-Cobos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorette","family":"Noiret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalda","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"9391_CR1","doi-asserted-by":"crossref","unstructured":"Acharya SK BV, Sreenivas V, Khanal S, Panda SK (2009) Efficacy of L-Ornithine L-Aspartate in acute liver failure: a doubleblind, randomized, placebo\u2014controlled study. Gastroenterology In Press","DOI":"10.1053\/j.gastro.2009.02.050"},{"key":"9391_CR2","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/S0168-8278(09)60736-4","volume":"50","author":"V Balasubramaniyan","year":"2009","unstructured":"Balasubramaniyan V, Davies NA, Wright G, Dalton RN, Turner C, Williams R, Jalan R, Mookerjee RP (2009) Treatment with infliximab increases E-Nos activity in cirrhosis through modulation of the Ddah-Adma pathway. J Hepatol 50:S270\u2013S270","journal-title":"J Hepatol"},{"key":"9391_CR3","doi-asserted-by":"crossref","first-page":"G145","DOI":"10.1152\/ajpgi.00097.2011","volume":"302","author":"V Balasubramaniyan","year":"2012","unstructured":"Balasubramaniyan V, Wright G, Sharma V, Davies NA, Sharifi Y, Habtesion A, Mookerjee RP, Jalan R (2012) Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 302:G145\u2013G152","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9391_CR4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071\u20131081","journal-title":"N Engl J Med"},{"key":"9391_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11011-008-9112-7","volume":"24","author":"CR Bosoi","year":"2009","unstructured":"Bosoi CR, Rose CF (2009) Identifying the direct effects of ammonia on the brain. Metab Brain Dis 24:95\u2013102","journal-title":"Metab Brain Dis"},{"key":"9391_CR6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ncomms2437","volume":"4","author":"R Cordoba","year":"2013","unstructured":"Cordoba R, Baturina TI, Sese J, Yu Mironov A, De Teresa JM, Ibarra MR, Nasimov DA, Gutakovskii AK, Latyshev AV, Guillamon I, Suderow H, Vieira S, Baklanov MR, Palacios JJ, Vinokur VM (2013) Magnetic field-induced dissipation-free state in superconducting nanostructures. Nature Commun 4:1437","journal-title":"Nature Commun"},{"key":"9391_CR7","doi-asserted-by":"crossref","unstructured":"Dadsetan S, Sorensen M, Bak LK, Vilstrup H, Ott P, Schousboe A, Jalan R, Keiding S, Waagepetersen HS (2012) Interorgan metabolism of ornithine phenylacetate (OP)-A novel strategy for treatment of hyperammonemia. Biochemical pharmacology","DOI":"10.1016\/j.bcp.2012.10.015"},{"key":"9391_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.22897","volume":"50","author":"NA Davies","year":"2009","unstructured":"Davies NA, Wright G, Ytrebo LM, Stadlbauer V, Fuskevag OM, Zwingmann C, Davies DC, Habtesion A, Hodges SJ, Jalan R (2009) L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology 50:155\u2013164","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"9391_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1005365825875","volume":"21","author":"F Feillet","year":"1998","unstructured":"Feillet F, Leonard JV (1998) Alternative pathway therapy for urea cycle disorders. J Inherit Metab Dis 21(Suppl 1):101\u2013111","journal-title":"J Inherit Metab Dis"},{"key":"9391_CR10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.mehy.2006.12.061","volume":"69","author":"R Jalan","year":"2007","unstructured":"Jalan R, Wright G, Davies NA, Hodges SJ (2007) L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 69:1064\u20131069","journal-title":"Med Hypotheses"},{"issue":"Suppl","key":"9391_CR11","first-page":"893A","volume":"52","author":"M Jover-Cobos","year":"2010","unstructured":"Jover-Cobos M, Noiret L, Habtesion A, Balasubramaniyan V, Sharifi Y, Romero-Gomez M, Davies N, Jalan R (2010) The mechanism behind synergistic action of l-ornithine and phenylacetate to reduce ammonia in Cirrhoticrats. Hepatology 52(Suppl):893A","journal-title":"Hepatology"},{"key":"9391_CR12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","volume":"25","author":"G Kircheis","year":"1997","unstructured":"Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, Hendricks R, Kruger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rosch W, Stauch S (1997) Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 25:1351\u20131360","journal-title":"Hepatology"},{"key":"9391_CR13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","volume":"13","author":"J Leiper","year":"2007","unstructured":"Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O\u2019Hara B, Rossiter S, Anthony S, Madhani M, Selwood D, Smith C, Wojciak-Stothard B, Rudiger A, Stidwill R, McDonald NQ, Vallance P (2007) Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 13:198\u2013203","journal-title":"Nat Med"},{"key":"9391_CR14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725\u2013734","journal-title":"Nat Rev Immunol"},{"key":"9391_CR15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9258(18)70632-7","volume":"229","author":"K Moldave","year":"1957","unstructured":"Moldave K, Meister A (1957) Synthesis of phenylacetylglutamine by human tissue. J Biol Chem 229:463\u2013476","journal-title":"J Biol Chem"},{"key":"9391_CR16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31815e7f58","volume":"43","author":"C Montoliu","year":"2009","unstructured":"Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V (2009) IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43:272\u2013279","journal-title":"J Clin Gastroenterol"},{"key":"9391_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11011-010-9184-z","volume":"25","author":"C Montoliu","year":"2010","unstructured":"Montoliu C, Rodrigo R, Monfort P, Llansola M, Cauli O, Boix J, Elmlili N, Agusti A, Felipo V (2010) Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis 25:39\u201348","journal-title":"Metab Brain Dis"},{"key":"9391_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","volume":"45","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C, Sen S, Williams R, Leiper J, Vallance P, Jalan R (2007) Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology 45:62\u201371","journal-title":"Hepatology"},{"key":"9391_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0197-0186(02)00040-2","volume":"41","author":"SW Olde Damink","year":"2002","unstructured":"Olde Damink SW, Deutz NE, Dejong CH, Soeters PB, Jalan R (2002a) Interorgan ammonia metabolism in liver failure. Neurochem Int 41:177\u2013188","journal-title":"Neurochem Int"},{"key":"9391_CR20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/jhep.2002.36497","volume":"36","author":"SW Olde Damink","year":"2002","unstructured":"Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB (2002b) Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 36:1163\u20131171","journal-title":"Hepatology"},{"key":"9391_CR21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.23938","volume":"52","author":"M Oria","year":"2010","unstructured":"Oria M, Chatauret N, Chavarria L, Romero-Gimenez J, Palenzuela L, Pardo-Yules B, Arranz JA, Bodega G, Raguer N, Cordoba J (2010) Motor-evoked potentials in awake rats are a valid method of assessing hepatic encephalopathy and of studying its pathogenesis. Hepatology 52:2077\u20132085","journal-title":"Hepatology"},{"key":"9391_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2011.06.026","volume":"56","author":"M Oria","year":"2012","unstructured":"Oria M, Romero-Gimenez J, Arranz JA, Riudor E, Raguer N, Cordoba J (2012) Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. J Hepatol 56:109\u2013114","journal-title":"J Hepatol"},{"key":"9391_CR23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1742-2094-7-66","volume":"7","author":"KV Rama Rao","year":"2010","unstructured":"Rama Rao KV, Jayakumar AR, Tong X, Alvarez VM, Norenberg MD (2010) Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes. J Neuroinflammation 7:66","journal-title":"J Neuroinflammation"},{"key":"9391_CR24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.47.4.571","volume":"47","author":"CJ Rees","year":"2000","unstructured":"Rees CJ, Oppong K, Al Mardini H, Hudson M, Record CO (2000) Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut 47:571\u2013574","journal-title":"Gut"},{"key":"9391_CR25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.gastro.2010.03.040","volume":"139","author":"R Rodrigo","year":"2010","unstructured":"Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139:675\u2013684","journal-title":"Gastroenterology"},{"key":"9391_CR26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14656561003724721","volume":"11","author":"M Romero-Gomez","year":"2010","unstructured":"Romero-Gomez M (2010) Pharmacotherapy of hepatic encephalopathy in cirrhosis. Expert Opin Pharmacother 11:1317\u20131327","journal-title":"Expert Opin Pharmacother"},{"key":"9391_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jhep.2004.03.021","volume":"41","author":"M Romero-Gomez","year":"2004","unstructured":"Romero-Gomez M, Ramos-Guerrero R, Grande L, de Teran LC, Corpas R, Camacho I, Bautista JD (2004) Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol 41:49\u201354","journal-title":"J Hepatol"},{"key":"9391_CR28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/hep.510300311","volume":"30","author":"C Rose","year":"1999","unstructured":"Rose C, Michalak A, Rao KV, Quack G, Kircheis G, Butterworth RF (1999) L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 30:636\u2013640","journal-title":"Hepatology"},{"key":"9391_CR29","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.21877","volume":"46","author":"C Rose","year":"2007","unstructured":"Rose C, Ytrebo LM, Davies NA, Sen S, Nedredal GI, Belanger M, Revhaug A, Jalan R (2007) Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. Hepatology 46:1883\u20131892","journal-title":"Hepatology"},{"key":"9391_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2012.112","volume":"92","author":"CF Rose","year":"2012","unstructured":"Rose CF (2012) Ammonia-lowering strategies for the treatment of hepatic encephalopathy. Clin Pharmacol Ther 92:321\u2013331","journal-title":"Clin Pharmacol Ther"},{"key":"9391_CR31","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00018-005-5089-0","volume":"62","author":"D Shawcross","year":"2005","unstructured":"Shawcross D, Jalan R (2005) The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 62:2295\u20132304","journal-title":"Cell Mol Life Sci"},{"key":"9391_CR32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","volume":"40","author":"DL Shawcross","year":"2004","unstructured":"Shawcross DL, Davies NA, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40:247\u2013254","journal-title":"J Hepatol"},{"key":"9391_CR33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jhep.2010.07.045","volume":"54","author":"DL Shawcross","year":"2011","unstructured":"Shawcross DL, Sharifi Y, Canavan JB, Yeoman AD, Abeles RD, Taylor NJ, Auzinger G, Bernal W, Wendon JA (2011) Infection and systemic inflammation, not ammonia, are associated with Grade 3\/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 54:640\u2013649","journal-title":"J Hepatol"},{"key":"9391_CR34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/291378a0","volume":"291","author":"I Smith","year":"1981","unstructured":"Smith I (1981) The treatment of inborn errors of the urea cycle. Nature 291:378\u2013380","journal-title":"Nature"},{"key":"9391_CR35","unstructured":"Ventura-Cots MS-TM, Torrens M, Arranz JA, Riudor E, Blanco A, Cordoba Cardona J (2012) Effects of ornithine penylacetate in patients with cirrhosis and upper gastrointestinal bleeding: an open-label, dose-escalating, single cohort study. Hepatology 56"},{"key":"9391_CR36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.expneurol.2004.08.008","volume":"190","author":"D Wong","year":"2004","unstructured":"Wong D, Dorovini-Zis K, Vincent SR (2004) Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood\u2013brain barrier. Exp Neurol 190:446\u2013455","journal-title":"Exp Neurol"},{"key":"9391_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1478-3231.2010.02302.x","volume":"31","author":"G Wright","year":"2011","unstructured":"Wright G, Noiret L, Olde Damink SW, Jalan R (2011) Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Liver Int 31:163\u2013175","journal-title":"Liver Int"},{"key":"9391_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11011-007-9071-4","volume":"22","author":"G Wright","year":"2007","unstructured":"Wright G, Shawcross D, Olde Damink SW, Jalan R (2007) Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis 22:375\u2013388","journal-title":"Metab Brain Dis"},{"key":"9391_CR39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1478-3231.2011.02698.x","volume":"32","author":"G Wright","year":"2012","unstructured":"Wright G, Vairappan B, Stadlbauer V, Mookerjee RP, Davies NA, Jalan R (2012) Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats. Liver Int 32:410\u2013419","journal-title":"Liver Int"},{"key":"9391_CR40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.22917","volume":"50","author":"LM Ytrebo","year":"2009","unstructured":"Ytrebo LM, Kristiansen RG, Maehre H, Fuskevag OM, Kalstad T, Revhaug A, Cobos MJ, Jalan R, Rose CF (2009) L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 50:165\u2013174","journal-title":"Hepatology"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-013-9391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-013-9391-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-013-9391-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T19:12:01Z","timestamp":1715022721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-013-9391-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9391"],"URL":"https:\/\/doi.org\/10.1007\/s11011-013-9391-5","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}